Xiaobin Zeng is a Research Professor in the
Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University;
the First Affiliated Hospital, Southern University of Science and Technology)
and Guangdong Provincial Key Laboratory of Regional Immunity and Diseases,
Shenzhen, China. Xiaobin Zeng received his Ph.D. in Biochemistry &
Molecular Biology from Wuhan University, and also holds a M.D. and M.S. in
Microbiology and Biochemical Pharmacy. Dr. Zeng’s research program is focused
on Chinese Herbs, cancer, the occurrence and development mechanism of cancer,
the effects of functional foods/nutraceuticals on cancer, and bioactive
compounds in natural products and herbal remedies for cancer. He has published
over 70 scientific papers in Advanced Science, Nature Communications, EMBO
Molecular Medicine, Cancer and Metastasis Reviews, Pharmacological Research,
Food and Chemical Toxicology, Biochemical Pharmacology, Bioorganic Chemistry,
Phytomedicine, Industrial Crops and Products and other journals. He has also
applied 25 patents in China, included 1 National Utility Model Patent and 24
patents for inventions and 8 patents have already been authorized.

Research
Focus

Dr. Zeng’s research program has focused on is
focused on Chinese Herbs, cancer, the occurrence and development mechanism of
cancer, the effects of functional foods/nutraceuticals on cancer, and bioactive
compounds in natural products and herbal remedies for cancer. Specific
interests include: 1) the occurrence and development mechanism of cancer; 2)
health benefits of phytochemicals and their derivatives in Traditional Chinese
Herbs with food and medicine homology; 3) Functional foods for disease
prevention and health promotion targeted at cancers, autoimmune diseases, and
inflammatory diseases; and 4) natural products and herbal formulations for
cancer.